Trial intelligence / Profile preview

Long-Term GL701 for Systemic Lupus Erythematosus

NCT00004665Phase 2Completed

Sponsor
National Center for Research Resources
Start
Jun 1995
Modality
Allosteric Modulators
01

Overview

A Phase 2 trial of dehydroepiandrosterone in systemic lupus erythematosus (SLE), sponsored by National Center for Research Resources. Started Jun 1995; status: completed.

02

Drugs

dehydroepiandrosterone
03

Conditions

systemic lupus erythematosus (SLE)

Beyond the preview

Go deeper on NCT00004665.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00004665.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call